Tislelizumab Combo Outperforms Alone Post-Lenvatinib
In a groundbreaking real-world study, researchers have shed light on the comparative efficacy of a dual-drug regimen combining tislelizumab with ...
In a groundbreaking real-world study, researchers have shed light on the comparative efficacy of a dual-drug regimen combining tislelizumab with ...
Hepatocellular carcinoma (HCC) stands as one of the most pressing health challenges today, being among the leading causes of cancer-related ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine